KRMD: KORU Medical Systems, Inc. Common Stock (DE) Company Profile & Statistics

About

Repro-Med Systems Inc. is engaged in the design and manufacture of medical devices directing resources to the global markets for emergency medical products and infusion therapy.

Info & Links

CEO

Linda Tharby

Headquarters

100 CORPORATE DRIVE
MAHWAH, NJ 07430, UNITED STATES

Auditor

Cherry Bekaert LLP

Share holders

431

Employees

KORU Medical Systems, Inc. Common Stock (DE) Statistics

Valuation Measures

Market Capitalization²

111.43M

Enterprise Value

102.44M

Enterprise Value/EBITDA(ttm)

-18.43

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.56

Price to Book(mrq)

10.03

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

63.40%

Operating Margin(ttm)

-14.59%

Profit Margin(ttm)

-18.08%

Return on Equity(ttm)

-24.60%

Return on Invested Capital(ttm)

-33.16%

Return on Assets(ttm)

-16.87%

Income Statement

Revenue(ttm)

33.65M

Revenue Per Share(ttm)

0.73

Gross Profit(ttm)

21.33M

EBITDA(ttm)³

-5.56M

Net Income Available to Common(ttm)

-6.07M

Diluted EPS(ttm)

-0.25

Share Statistics

Beta (5Y Monthly)

0.45

52-Week Change

16.54%

S&P 500 52-Week Change

6.83%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

45.96M

Dividend Yield

0.00%

Float⁴

34.10M

% Held by Insiders

25.60%

% Held by Institutions

58.60%

Balance Sheet

Total Cash(mrq)

9.58M

Total Cash Per Share(mrq)

0.21

Total Debt(mrq)

589.40K

Total Debt/Equity(mrq)

3.51%

Current Ratio(mrq)

2.66%

Quick Ratio(mrq)

2.37%

Book Value Per Share(mrq)

0.37

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.01

Free Cash Flow(ytd)

-1.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

KRMD

KORU Medical Systems, Inc. Common Stock (DE)

KORU Medical Systems, Inc. Common Stock (DE) Profile